[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inovio Pharma (INO)

Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 118,908
  • Shares Outstanding, K 103,398
  • Annual Sales, $ 70 K
  • Annual Income, $ -84,950 K
  • EBIT $ -79 M
  • EBITDA $ -76 M
  • 60-Month Beta 1.52
  • Price/Sales 1,733.91
  • Price/Cash Flow N/A
  • Price/Book 16.94

Options Overview Details

View History
  • Implied Volatility 155.08% (-23.37%)
  • Historical Volatility 160.60%
  • IV Percentile 20%
  • IV Rank 12.28%
  • IV High 776.72% on 01/02/26
  • IV Low 68.09% on 01/28/26
  • Expected Move (DTE 3) 0.1190 (10.35%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 1,136
  • Volume Avg (30-Day) 3,356
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 91,111
  • Open Int (30-Day) 72,245
  • Expected Range 1.0310 to 1.2690

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.20
  • Number of Estimates 2
  • High Estimate $-0.19
  • Low Estimate $-0.20
  • Prior Year $-0.44
  • Growth Rate Est. (year over year) +54.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5632 +104.19%
on 07/30/26
1.1500 unch
on 08/17/26
+0.0300 (+2.68%)
since 07/17/26
3-Month
0.5632 +104.19%
on 07/30/26
1.4500 -20.69%
on 05/22/26
-0.1500 (-11.54%)
since 05/15/26
52-Week
0.5632 +104.19%
on 07/30/26
2.9789 -61.40%
on 09/09/25
-0.7100 (-38.17%)
since 08/15/25

Most Recent Stories

More News
Inovio: Q2 Earnings Snapshot

Inovio: Q2 Earnings Snapshot

INO : 1.1500 (+5.50%)
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights

PLYMOUTH MEETING, Pa. , Aug. 12, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related...

INO : 1.1500 (+5.50%)
INOVIO to Report Second Quarter Financial Results on August 12, 2026

PLYMOUTH MEETING, Pa. , Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related...

INO : 1.1500 (+5.50%)
INOVIO Announces Pricing of $20.0 Million Public Offering

PLYMOUTH MEETING, Pa. , July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and...

INO : 1.1500 (+5.50%)
INOVIO Announces Proposed Public Offering

PLYMOUTH MEETING, Pa. , July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and...

INO : 1.1500 (+5.50%)
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm

NEW YORK , June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ:...

INO : 1.1500 (+5.50%)
INOVIO to Participate in Upcoming Scientific and Investor Conferences

PLYMOUTH MEETING, Pa. , May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related...

INO : 1.1500 (+5.50%)
Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances

Inovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young...

INO : 1.1500 (+5.50%)
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China

PLYMOUTH MEETING, Pa. , May 21, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related...

INO : 1.1500 (+5.50%)
Inovio: Q1 Earnings Snapshot

Inovio: Q1 Earnings Snapshot

INO : 1.1500 (+5.50%)

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 1.2967
2nd Resistance Point 1.2233
1st Resistance Point 1.1867
Last Price 1.1500
1st Support Level 1.0767
2nd Support Level 1.0033
3rd Support Level 0.9667

See More

52-Week High 2.9789
Fibonacci 61.8% 2.0561
Fibonacci 50% 1.7710
Fibonacci 38.2% 1.4860
Last Price 1.1500
52-Week Low 0.5632

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.